IRIS
RIGAMONTI, Cristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.715
NA - Nord America 2.856
AS - Asia 2.486
SA - Sud America 508
AF - Africa 114
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.696
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.734
RU - Federazione Russa 1.056
IE - Irlanda 751
SG - Singapore 739
IT - Italia 553
CN - Cina 432
VN - Vietnam 402
BR - Brasile 364
HK - Hong Kong 343
DE - Germania 315
SE - Svezia 293
FR - Francia 195
UA - Ucraina 186
IN - India 139
GB - Regno Unito 92
FI - Finlandia 83
CA - Canada 76
KR - Corea 76
ID - Indonesia 71
AR - Argentina 53
TR - Turchia 42
BD - Bangladesh 41
NL - Olanda 39
BJ - Benin 32
JP - Giappone 31
MX - Messico 31
ZA - Sudafrica 30
IR - Iran 29
IQ - Iraq 28
AT - Austria 27
PK - Pakistan 27
ES - Italia 26
PL - Polonia 26
EC - Ecuador 23
CL - Cile 22
CZ - Repubblica Ceca 22
MY - Malesia 16
AU - Australia 14
TH - Thailandia 13
VE - Venezuela 13
PY - Paraguay 12
PE - Perù 11
TW - Taiwan 10
EG - Egitto 9
CH - Svizzera 8
KE - Kenya 8
LT - Lituania 8
MA - Marocco 8
PH - Filippine 8
BE - Belgio 7
CO - Colombia 7
NG - Nigeria 7
IL - Israele 6
RO - Romania 5
AE - Emirati Arabi Uniti 4
DZ - Algeria 4
MO - Macao, regione amministrativa speciale della Cina 4
PT - Portogallo 4
SA - Arabia Saudita 4
SN - Senegal 4
DK - Danimarca 3
EU - Europa 3
GR - Grecia 3
JM - Giamaica 3
KG - Kirghizistan 3
LB - Libano 3
LY - Libia 3
NP - Nepal 3
RS - Serbia 3
UY - Uruguay 3
AZ - Azerbaigian 2
BH - Bahrain 2
CU - Cuba 2
ET - Etiopia 2
GA - Gabon 2
NO - Norvegia 2
SI - Slovenia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BZ - Belize 1
CD - Congo 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GM - Gambi 1
GT - Guatemala 1
HN - Honduras 1
KH - Cambogia 1
KZ - Kazakistan 1
LV - Lettonia 1
MK - Macedonia 1
MT - Malta 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
Totale 9.693
Salva come PNG Salva come JPEG
Città #
Dublin 739
San Jose 408
Hong Kong 327
Singapore 322
Jacksonville 309
Ashburn 234
Moscow 134
Beijing 126
Ho Chi Minh City 108
Lauterbourg 105
Chandler 99
Council Bluffs 95
Hanoi 86
Los Angeles 86
Lawrence 82
Princeton 82
Wilmington 71
San Mateo 69
Novara 63
New York 60
Jakarta 55
Dearborn 54
Seoul 53
Munich 52
Piemonte 49
Milan 45
Helsinki 43
Orem 41
Turin 41
Buffalo 40
São Paulo 39
Dong Ket 36
Frankfurt am Main 34
Chennai 33
Cotonou 32
Dallas 32
Santa Clara 31
Montreal 28
Bremen 27
Nuremberg 26
Ann Arbor 25
Vercelli 25
Redondo Beach 24
Boardman 22
Warsaw 22
Andover 21
Denver 21
Tokyo 21
Toronto 21
Amsterdam 19
Brno 19
Brooklyn 19
London 19
Johannesburg 18
Da Nang 17
Falkenstein 17
Norwalk 16
Stockholm 16
Vienna 16
Mexico City 15
Rome 15
Houston 14
Monmouth Junction 13
Poplar 13
Boston 12
Haiphong 12
Istanbul 12
Rio de Janeiro 12
Santiago 12
Dhaka 11
Phoenix 11
Ankara 10
Augusta 10
Guangzhou 10
Kocaeli 10
Mumbai 10
Paris 10
Shanghai 10
Tianjin 10
West Jordan 10
Ardabil 9
Atlanta 9
Baghdad 9
Bologna 9
Chicago 9
Guayaquil 9
Hangzhou 9
The Dalles 9
Alessandria 8
City of London 8
Fairfield 8
Gangbuk-gu 8
Nairobi 8
Nanjing 8
Philadelphia 8
Seattle 8
Turku 8
Asunción 7
Bangkok 7
Biên Hòa 7
Totale 5.181
Salva come PNG Salva come JPEG
Nome #
Midterm functional sequelae and implications in rehabilitation after COVID19. A cross-sectional study 371
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 248
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 190
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 174
Liver infection and COVID-19: the electron microscopy proof and revision of the literature 169
Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort 164
Clinical Relevance of Liver Involvement in the Clinical Course of Systemic Sclerosis 160
Response rates to direct antiviral agents among hepatitis C virus infected patients who develop hepatocellular carcinoma following direct antiviral agents treatment 156
Association between red cell distribution width and response to methotrexate in rheumatoid arthritis 155
Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge 155
SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort 134
Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors 131
Gas6/TAM system: A key modulator of the interplay between inflammation and fibrosis 130
Chronic hepatitis C is mild in menstruating women 125
Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis 125
Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents 123
17β-Oestradiol Protects from Hepatitis C Virus Infection through Induction of Type I Interferon 122
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 120
Liver stiffness, not fat liver content, predicts the length of QTc interval in patients with chronic liver disease 115
Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment 112
Coronavirus Disease 2019 (COVID‐19) in autoimmune hepatitis: a lesson from immunosuppressed patients 112
Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach 112
HSD17B13 and other liver fat-modulating genes predict development of hepatocellular carcinoma among HCV-positive cirrhotics with and without viral clearance after DAA treatment 112
CYP2E1 autoantibodies in liver diseases 111
Adequate vs. deep response to UDCA in PBC: To what extent and under what conditions is normal ALP level associated with complication-free survival gain? 110
Antiphospholipid antibodies associated with alcoholic liver disease specifically recognise oxidised phospholipids 110
Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms 108
Rates of symptomatic SARS-CoV-2 infection in patients with autoimmune liver diseases in Northern Italy: a telemedicine study 106
Heterozygous β-globin gene mutations as a risk factor for iron accumulation and liver fibrosis in chronic hepatitis C 105
Elastography in Liver-Transplanted Patients 103
Reduced activity of B lymphocytes, recognised by Sysmex XN-2000™ haematology analyser, predicts mortality in patients with coronavirus disease 2019 103
Role of Gas6 and TAM Receptors in the Identification of Cardiopulmonary Involvement in Systemic Sclerosis and Scleroderma Spectrum Disorders 102
Giant liver fibrous tumours metastatic from atypical recurrent meningeal neoplasia 101
Chronic hepatitis C treated with phlebotomy alone: biochemical and histological outcome 100
Impact of the COVID-19 outbreak on an Italian cohort of systemic sclerosis patients 98
Detection of auto-antibodies against cytochrome P4502E1 (CYP2E1) in chronic hepatitis C 97
Biochemical criteria at 1 year are not robust indicators of response to ursodeoxycholic acid in early primary biliary cirrhosis: Results from a 29-year cohort study 97
High reproducibility of spleen stiffness measurement by vibration-controlled transient elastography with a spleen-dedicated module 94
Anti-phospholipid antibodies associated with alcoholic liver disease target oxidized phosphatidylserine on apoptotic cell plasma membranes 93
Authors’ response re: “The non-invasive diagnosis of cirrhosis using the Fibroscan must be performed with cause-specific stiffness cut-offs” 91
Clinical update on risks and efficacy of anti-SARS-CoV-2 vaccines in patients with autoimmune hepatitis and summary of reports on post-vaccination liver injury 91
Excellent outcome in patients with primary biliary cholangitis in Northwest Italy followed up for up to 30 years 90
Spleen stiffness measurement predicts decompensation and rules out high-risk oesophageal varices in primary biliary cholangitis 90
Combination of oxidative stress and steatosis is a risk factor for fibrosis in alcohol-drinking patients with chronic hepatitis C 89
Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis 88
Outcome of COVID-19 in Patients with Autoimmune Hepatitis: an International Multi-Centre Study 88
Pathophysiological Role and Therapeutic Implications of Vitamin D in Autoimmunity: Focus on Chronic Autoimmune Diseases 87
Serum autoantibodies against cytochrome P450 2E1 (CYP2E1) predict severity of necroinflammation of recurrent hepatitis C 85
Primary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges 83
Development and validation of a scoring system to predict response to obeticholic acid in primary biliary cholangitis 81
Risk of hepatocellular carcinoma and death among cirrhotics who carry genetic variants of epidermal growth factor, Adiponutrin and 17β-Hydroxysteroid Dehydrogenase-13: a long-term cohort study 79
Delivering adjuvant and neoadjuvant treatments in the early stages of hepatocellular carcinoma 79
Exposure to Plasma From Non-alcoholic Fatty Liver Disease Patients Affects Hepatocyte Viability, Generates Mitochondrial Dysfunction, and Modulates Pathways Involved in Fat Accumulation and Inflammation 79
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 79
Can protocol liver biopsy be avoided to evaluate post-transplant hepatitis C recurrence? Transient elastography makes it possible 79
Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma 78
Evaluation of liver fibrosis in chronic hepatitis C with a computer-assisted morphometric method 77
Severe thombocytopenia and clinical bleeding associated with rituximab infusion in a lynphoma patient with massive splenomegaly without leukemic invasion 77
The evolving landscape of autoimmune hepatitis: an ambispective cohort study 76
Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial 76
The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: clinical and virological outcomes 75
Gender and liver fibrosis in chronic hepatitis: the role of iron status 75
Transient elastography in the assessment of liver fibrosis in adult thalassemia patients 73
Moderate alcohol consumption increases oxidative stress in patients with chronic hepatitis C 71
Spleen Stiffness Measured by Transient Elastography Accurately Predicts Esophageal Varices in Liver Cirrhosis 70
Severe thrombocytopenia and clinical bleeding associated with rituximab infusion in a lymphoma patient with massive splenomegaly without leukemic invasion 69
Post-liver transplantation graft biopsies should not be used to assess the IL28B donor genotype in HCV recipients 68
SURVIVAL FOLLOWING THE DEVELOPMENT OF ASCITES AND/OR PERIPHERAL OEDEMA IN PRIMARY BILIARY CIRRHOSIS: A STAGED PROGNOSTIC MODEL 68
Transjugular liver biopsy: The Tru-cut needle might be better for stiffer livers 68
Hepatocellular carcinoma after direct-acting antiviral agents: Can liver stiffness kinetics help identify patients at lower risk? 67
Emerging Issues in the Immunopathogenesis, Diagnosis and Clinical Management of Primary Biliary Cirrhosis Associated with Systemic Sclerosis 67
Interaction between calcineurin inhibitors and IL-28B rs12979860 C>T polymorphism and response to treatment for post-transplant recurrent hepatitis C 67
Iron, hepatic stellate cells and fibrosis in chronic hepatitis C 66
Do not trivialize the Fibroscan® examination, value its accuracy 66
Ursodeoxycholic acid improves bilirubin but not albumin in primary biliary cirrhosis: further evidence for nonefficacy 66
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis 66
Transient elastography in the early prediction of progressive recurrent hepatitis C following liver transplantation 65
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis 64
ERCP and short-term stent-trial in patients with anastomotic biliary stricture following liver transplantation 63
Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis 62
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 62
Lipid peroxidation contributes to immune reactions associated with alcoholic liver disease 61
Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or C 61
High prevalence of acute onset autoimmune hepatitis in males: A real-life cohort from Northern Italy 61
Predicting the advent of ascites and other complications in primary biliary cirrhosis: a staged model approach 60
Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease 60
Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis 59
Integrating Quality of Life and Survival in Systemic Therapy for Advanced Hepatocellular Carcinoma: A Network Meta-Analysis 58
Prognostic Models for Survival in Patients with Stable Cirrhosis: A Multicenter Cohort Study 58
Diagnosis of cirrhosis by transient elastography: what is hidden behind misleading results 58
Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients 58
Position paper of the Italian Association for the Study of the Liver (AISF): Management and treatment of primary biliary cholangitis 57
Feasibility and reproducibility of spleen transient elastography and its role in combination with liver transient elastography for predicting the severity of chronic viral hepatitis 57
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C 57
Non-invasive assessment of portal hypertension in patients with primary biliary cholangitis is affected by severity of cholestasis 56
LIVER BIOPSY TECHNIQUES: AUTOMATED ASPIRATION NEEDLES PROVIDE ADEQUATE TISSUE SAMPLES 56
Transient elastography predicts fibrosis progression in patients with recurrent hepatitis C after liver transplantation 56
Transient elastography identifies liver recipients with nonviral graft disease after transplantation: A guide for liver biopsy 56
Prospective study of natural killer cell phenotype in recurrent hepatitis C virus infection following liver transplantation 55
Long term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years 55
Totale 9.412
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.763
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.763
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021154 0 0 0 0 0 0 0 0 0 31 81 42
2021/2022613 17 47 79 44 38 17 43 20 60 37 82 129
2022/20231.418 155 84 70 19 69 87 56 60 718 19 48 33
2023/2024767 38 61 43 23 107 38 142 60 28 42 54 131
2024/20251.568 30 25 110 41 56 158 215 177 324 102 67 263
2025/20264.580 203 169 310 685 454 347 781 819 364 448 0 0
Totale 9.898